Smit Kour

689 total citations
18 papers, 542 citations indexed

About

Smit Kour is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Smit Kour has authored 18 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Smit Kour's work include Synthesis and biological activity (3 papers), Advanced Breast Cancer Therapies (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Smit Kour is often cited by papers focused on Synthesis and biological activity (3 papers), Advanced Breast Cancer Therapies (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Smit Kour collaborates with scholars based in India and United States. Smit Kour's co-authors include Amarnath Natarajan, Sandeep Rana, Muhammad Zahid, Caroline M. Robb, Smitha Kizhake, Yogesh A. Sonawane, Jacob I. Contreras, Margaret Taylor, Mohammad Abid and Daryl J. Murry and has published in prestigious journals such as Journal of Biological Chemistry, Chemical Communications and International Journal of Pharmaceutics.

In The Last Decade

Smit Kour

18 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Smit Kour India 10 351 192 92 85 63 18 542
Trang Thi France 5 451 1.3× 151 0.8× 34 0.4× 264 3.1× 28 0.4× 5 703
Zhonghui Lin China 16 302 0.9× 61 0.3× 55 0.6× 36 0.4× 33 0.5× 34 567
Tiantao Gao China 12 297 0.8× 96 0.5× 20 0.2× 35 0.4× 24 0.4× 18 460
В. П. Николин Russia 15 315 0.9× 202 1.1× 45 0.5× 20 0.2× 14 0.2× 60 580
Nagaraju Anreddy United States 13 249 0.7× 279 1.5× 28 0.3× 27 0.3× 42 0.7× 15 457
Aoife Devery United Kingdom 10 266 0.8× 183 1.0× 17 0.2× 140 1.6× 56 0.9× 15 480
Daiju Ichikawa Japan 14 196 0.6× 62 0.3× 33 0.4× 37 0.4× 30 0.5× 35 494
Lina Han United States 16 439 1.3× 144 0.8× 264 2.9× 27 0.3× 13 0.2× 56 743
Xiaojie Li China 3 376 1.1× 133 0.7× 146 1.6× 14 0.2× 11 0.2× 5 578
Lisa Polin United States 12 234 0.7× 111 0.6× 36 0.4× 33 0.4× 15 0.2× 19 392

Countries citing papers authored by Smit Kour

Since Specialization
Citations

This map shows the geographic impact of Smit Kour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Smit Kour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Smit Kour more than expected).

Fields of papers citing papers by Smit Kour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Smit Kour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Smit Kour. The network helps show where Smit Kour may publish in the future.

Co-authorship network of co-authors of Smit Kour

This figure shows the co-authorship network connecting the top 25 collaborators of Smit Kour. A scholar is included among the top collaborators of Smit Kour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Smit Kour. Smit Kour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Rana, Sandeep, Smit Kour, Smitha Kizhake, et al.. (2022). Dimers of isatin derived α-methylene-γ-butyrolactone as potent anti-cancer agents. Bioorganic & Medicinal Chemistry Letters. 65. 128713–128713. 7 indexed citations
2.
Kour, Smit, Sandeep Rana, Smitha Kizhake, et al.. (2022). Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells. Journal of Biological Chemistry. 298(5). 101890–101890. 8 indexed citations
3.
Kour, Smit, Sandeep Rana, Smitha Kizhake, et al.. (2021). Stapling proteins in the RELA complex inhibits TNFα-induced nuclear translocation of RELA. RSC Chemical Biology. 3(1). 32–36. 7 indexed citations
4.
Kour, Smit, et al.. (2020). Prevalence of mastitis in cow heifers and associated risk factors in Himalayan region, India. Journal of Environmental Biology. 41(4). 796–802. 1 indexed citations
5.
Rana, Sandeep, Smit Kour, Yogesh A. Sonawane, et al.. (2020). Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK. Chemical Biology & Drug Design. 96(2). 773–784. 13 indexed citations
6.
Robb, Caroline M., Smit Kour, Jacob I. Contreras, et al.. (2020). Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 11(25). 2462–2463. 3 indexed citations
7.
Verma, Pankaj, et al.. (2019). Association between maxillary and mandibular apical base lengths and severity of dental crowding or spacing in Class II malocclusion subjects: An in-vitro study. Journal of Clinical and Experimental Dentistry. 11(1). 0–0. 2 indexed citations
8.
Rana, Sandeep, Mourad Bendjennat, Smit Kour, et al.. (2019). Selective degradation of CDK6 by a palbociclib based PROTAC. Bioorganic & Medicinal Chemistry Letters. 29(11). 1375–1379. 108 indexed citations
9.
Kour, Smit, Sandeep Rana, Jacob I. Contreras, et al.. (2019). CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax. Molecular Pharmacology. 96(4). 419–429. 21 indexed citations
10.
Robb, Caroline M., Jacob I. Contreras, Smit Kour, et al.. (2017). Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC). Chemical Communications. 53(54). 7577–7580. 177 indexed citations
11.
Robb, Caroline M., Smit Kour, Jacob I. Contreras, et al.. (2017). Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 9(4). 5216–5232. 25 indexed citations
12.
Khare, Vaibhav, Amarinder Singh, Girish Mahajan, et al.. (2016). Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy. European Journal of Pharmaceutical Sciences. 92. 183–193. 29 indexed citations
13.
Verma, Vikas, Devinder Kumar, Balasubramanian Narasimhan, et al.. (2015). Iodobenzene diacetate-mediated isomerization of pyrazolyl chalcones and their cytotoxicity and anti-microbial activity. Journal of Chemical Sciences. 127(3). 413–423. 8 indexed citations
14.
Khare, Vaibhav, Smit Kour, Noor Alam, et al.. (2014). Synthesis, characterization and mechanistic-insight into the anti-proliferative potential of PLGA-gemcitabine conjugate. International Journal of Pharmaceutics. 470(1-2). 51–62. 46 indexed citations
15.
Gupta, Prem N., Chetan Nehate, Noor Alam, et al.. (2014). Development and evaluation of paclitaxel loaded PLGA:poloxamer blend nanoparticles for cancer chemotherapy. International Journal of Biological Macromolecules. 69. 393–399. 24 indexed citations
16.
Singh, Baljinder, Santosh Kumar Guru, Smit Kour, et al.. (2013). Synthesis, antiproliferative and apoptosis-inducing activity of thiazolo[5,4-d]pyrimidines. European Journal of Medicinal Chemistry. 70. 864–874. 28 indexed citations
17.
Kaul, Sanjana, et al.. (2013). Polymerase Chain Reaction: Restriction Fragment Length Polymorphism Differentiates the Environmental and Clinically Important Fungal Isolates. National Academy Science Letters. 36(2). 139–146. 2 indexed citations
18.
Atal, C.K., et al.. (1984). Non-narcotic orally effective, centrally acting analgesic from an ayurvedic drug. Journal of Ethnopharmacology. 11(3). 309–317. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026